Aixtron's Order Book Is Overflowing — So Why Is the Share Price Still Nursing Wounds?
Published on 08/04/2026 at 16:15 | Redaktion boerse-global.de
The arithmetic looks baffling at first glance. Aixtron booked €214.5 million in new orders during the second quarter of 2026, an 81 percent surge that blew past consensus forecasts of €185 million to €197 million. Its order backlog swelled to roughly €457 million by the end of the first half. And yet the share has shed 23 percent over the past five weeks, with the stock still trading nearly a quarter below its 50-day moving average.
The explanation lies in the timing gap between when orders land and when revenue actually hits the income statement. Aixtron's customers commit today, but the company often doesn't deliver and recognise those sales until many months later. That lag is now pinching hard: first-half revenue fell 30 percent to €174.5 million, while the operating result swung to a loss of €7.6 million, weighed down by thin volumes and one-off costs from personnel measures taken at the start of the year. Investors who had positioned for immediate profit growth pulled the ripcord.
The second quarter alone tells a similar story. Revenue slipped 16 percent to €115 million, with earnings before interest and taxes of €14.7 million. Management has guided for third-quarter sales between €160 million and €200 million, and reaffirmed the full-year target of €560 million, plus or minus €30 million, with a gross margin of 42 percent and an Ebit margin of 17 to 20 percent.
Silicon carbide steps aside as optoelectronics takes the wheel
The composition of that order boom marks a strategic shift. Optoelectronics — long overshadowed by silicon carbide as Aixtron's marquee growth story — contributed roughly three-quarters of the quarterly order intake, with the segment alone accounting for €161 million. The driver is familiar to anyone tracking the AI infrastructure buildout: hyperscale data centres need high-performance laser systems for optical data transmission, and Aixtron makes the deposition equipment used to produce them.
The company is simultaneously deepening its push into gallium nitride. Its partnership with ROHM Semiconductor is positioning the G10 platform as a standard for next-generation power devices. That positioning helps explain why, despite the recent correction, the stock remains up 122 percent since the start of the year — a figure that underscores just how far the shares had run before the pullback.
A cushioned balance sheet funds the expansion
Aixtron is not financing its transformation on hope alone. Hefty customer prepayments and a placed convertible bond have padded the balance sheet, leaving the company with roughly €816 million in liquid funds at the end of the first half. That war chest is earmarked for a production ramp-up and a new manufacturing site in Malaysia, which is slated to shorten supply chains into key Asian markets from 2027 onward.
The same discipline that keeps a balance sheet healthy applies to workplace safety — yet many employers overlook gaps in their risk documentation until it's too late. A free toolkit with 41 ready-to-use templates and checklists helps you identify hazards and keep compliant records without hours of paperwork. Download the free Risk Assessment Toolkit
Analysts split the difference
JPMorgan's response to the numbers captures the market's ambivalence. Analyst Craig A. McDowell trimmed his price target from €70 to €60 on Monday while maintaining an "Overweight" rating — a combination that looks contradictory until you consider the context. After a conversation with Chief Financial Officer Christian Danninger, which McDowell described as "extremely positive," the analyst pointed to optoelectronics demand as a pillar of support. The lingering uncertainty, in his view, is when the power electronics business will return to growth — a segment that will be decisive for future earnings momentum. The target cut alongside a reiterated buy recommendation suggests the bank still likes the operational trajectory but believes the valuation had run ahead of itself after months of sharp gains.
Chart signals point to stabilisation, not collapse
Technical indicators offer a mixed read. The relative strength index sits at 42.4, suggesting the stock is neither oversold nor overheated, while the price remains comfortably above its long-term average. The market's immediate reaction to the quarterly numbers was positive — the shares closed Monday up 3.24 percent at €37.61 — but that bounce only partially repairs the damage from the preceding weeks. On a year-to-date basis, the stock is still up 117.34 percent.
While Aixtron's execution risk is about converting orders into revenue, your own business faces a different kind of compliance risk every day. Over 37,000 UK companies rely on a free Health & Safety Toolkit covering everything from fire safety to COSHH and PUWER — so you can meet your legal duties with confidence. Get the free Health & Safety Toolkit
The decisive question for the second half is execution: whether that mountain of orders can be converted into recognised revenue quickly enough to keep the €560 million target within reach. If the conversion accelerates, the recent weakness may well be remembered as a painful but healthy correction to an overheated rally. The underlying growth narrative around AI infrastructure and the energy transition, for now, remains intact.
